Taiwan FDA registration 6af6dc8ac2ac6bae405f6c66104b713b
Tiandai transcatheter mitral valve replacement system
TW: 天黛經導管二尖瓣瓣膜置換系統
Taiwan·Risk Class 3·Abbott Medical·Registered Jun 19, 2022 – Jun 19, 2027ActiveRegistration details
- Analysis ID
- 6af6dc8ac2ac6bae405f6c66104b713b
- Customs Code
- DHA05603461400
Company information
- Manufacturer
- Abbott Medical
- Manufacturer Country
- United States
- Authorized Representative
- Abbott Medical Taiwan Co.
Product details
- Intended Use
- Details are as detailed as approved Chinese instructions
- Product Type (Level 1)
- E Cardiovascular Medicine Science
- Product Type (Level 2)
- E.3925 Hypocardial membrane substitutions
- Import Information
- import
Dates and status
- Registration Date
- Jun 19, 2022
- Expiry Date
- Jun 19, 2027
- Cancellation Date
- Aug 23, 2024
About this record
Access comprehensive regulatory information for Tiandai transcatheter mitral valve replacement system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 6af6dc8ac2ac6bae405f6c66104b713b and manufactured by Abbott Medical. The authorized representative in Taiwan is Abbott Medical Taiwan Co..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices